Vaccination gaps persist years after sepsis, despite rising uptake
Sepsis survivors in Germany carried substantial immunization gaps long after their index illness, even as vaccination rates improved over time. In a survey of 174 adults drawn from the Mid-German Sepsis Cohort 6 to 8 years after enrollment, self-reported coverage rose for influenza and pneumococcal vaccination, yet neither pathogen reached anything close to universal protection. Full coverage against SARS-CoV-2 was higher, but still left a clinically important minority without complete protection against a virus that can hit medically fragile patients hard.
The pattern fits the biology of post-sepsis survivorship. Sepsis is not a one-time event that ends at hospital discharge; immune dysfunction can linger, leaving patients exposed to recurrent infections, rehospitalization, and a new cycle of deconditioning. Vaccination should be one of the simplest ways to blunt that risk. Instead, the data show a population that still depends heavily on whether primary care teams actively check vaccination status, raise the topic, and remove practical barriers.
Immunization coverage improved, but large deficits remained
At the time of the survey, 70.7% of survivors were vaccinated against influenza, up from 57.3% before sepsis. Pneumococcal vaccination showed a larger relative climb, rising from 31.4% pre-sepsis to 60.5% years later. A total of 135 patients, or 77.6%, had full SARS-CoV-2 vaccination coverage at the time of the survey.
The increase over time is encouraging, but the absolute numbers matter more at the bedside. Even after years of follow-up, roughly three in ten survivors still lacked influenza protection, and nearly four in ten remained without complete pneumococcal vaccination. Those are not trivial omissions in a cohort enriched for chronic illness, prior critical care exposure, and vulnerability to respiratory infections. Pneumococcal vaccination is especially relevant here because pneumonia is a common and dangerous driver of rehospitalization after sepsis.
One sentence captures the core problem: access and follow-through still decide whether many of these patients get protected.
Primary care contact carried the strongest association with vaccination
Among the predictors examined, general practitioner involvement stood out. Vaccination counselling by a general practitioner increased the odds of influenza vaccination 5.5-fold and pneumococcal vaccination 3.2-fold in the multivariable models. A routine review of vaccination status was also associated with a 4.7-fold increase in influenza vaccination and a 3.1-fold increase in SARS-CoV-2 vaccination.
These are large effects for something relatively low-tech. No novel biologic agent was required, and no complex intervention was needed. A clinician asked, reviewed the record, and recommended vaccination. In a population with chronic immune vulnerability, those simple interactions appear to carry disproportionate weight because they convert passive eligibility into action. The finding also fits basic preventive-care psychology: survivors may not spontaneously prioritize vaccines after a dramatic hospitalization, especially if they are still navigating fatigue, cognitive changes, mobility limitations, or competing medical appointments.
The survey’s risk-perception framework reinforces that point. Participants were asked about perceived severity, susceptibility, danger, and vaccine effectiveness, along with physician-related cues to action. In practice, those variables describe the emotional and cognitive space in which a survivor decides whether to accept vaccination. A recommendation from a trusted general practitioner can tilt that decision more effectively than abstract public health messaging.
Age and education influenced influenza uptake more than other vaccines
Higher age and intermediate versus low education increased the odds of influenza vaccination. No sociodemographic association emerged for pneumococcal or SARS-CoV-2 vaccination. The absence of consistent demographic gradients suggests that the barriers are not simply a matter of age, sex, or living situation. Instead, they likely reflect the structure of follow-up care, how often vaccination is reviewed, and whether patients are offered a clear recommendation at a visit where they are already dealing with other medical concerns.
In other words, the vaccine gap is not fully explained by who the patient is. It is also explained by how the healthcare system meets that patient after sepsis.
Mobility, waiting time, and infection fears blocked uptake
Among the 92 patients with at least one missing vaccination, three barriers dominated: impaired mobility, long waiting times in the practice, and fear of infection in the practice. These are practical obstacles, but they also reflect the lived reality of post-sepsis recovery. A patient with impaired mobility may need extra planning just to attend a primary care visit. Waiting rooms may carry a heavier psychological burden for survivors who have already spent weeks in intensive care and now fear exposure to another infection. Even when a vaccine is recommended, the pathway to receiving it can break down at the level of logistics.
The barrier profile points to a specific clinical response. Vaccination after sepsis should not depend on a patient deciding independently, months or years later, to bring the topic up. Proactive review during routine follow-up is more realistic. So is making vaccination easier to obtain during the same visit, minimizing waiting, and treating infection fear as a concrete safety concern rather than a vague hesitation.
Sepsis aftercare needs vaccination review as a routine task
This survey adds a practical message to the literature on sepsis survivorship: immunization should be treated as part of long-term aftercare, not as an optional add-on. Survivors remain at risk for recurrent infection, and the data suggest that vaccination status can improve over time when clinicians actively intervene. Yet the persistence of sizable gaps, especially for pneumococcal protection, shows how much opportunity remains.
A structured vaccination review may be one of the most efficient interventions available in post-sepsis care. It is inexpensive, can be done quickly, and aligns with the observed association between physician counselling and higher uptake. The study also uses a real-world cohort that includes patients years after critical illness, which makes the findings especially relevant for outpatient practice rather than short-term hospital protocols.
Still, the results rest on self-reported vaccination status, and the survey design cannot prove causation. The multiple regression analyses identify strong associations, not definitive intervention effects. Even so, the clinical direction is hard to ignore: survivors who get asked, reminded, and checked are more likely to be vaccinated, while those facing mobility limitations, long waits, and infection concerns are easier to miss. Those are the patients most likely to benefit from a more deliberate follow-up structure.